Thus, despite the dramatic impact that CFTR modulator therapy will likely have on the natural history of CF lung disease over the coming years, considering the central role of inflammation in lung damage, research focused on the control of the inflammatory process still remains a priority. Here, CFTR is linked to lung disorder.